Donald W. Joseph Joins Renal Board
June 29, 2006
Donald W. Joseph has been appointed to the Board of Directors for Renal Solutions. Renal is the exclusive provider of advanced sorbent hemodialysis products and services for treatment of patients with renal failure. Mr. Joseph is currently President & CEO of Sorbent Therapeutics, Inc., a company focused on solutions for patients with fluid balance deficiencies. Previously, Mr. Joseph served as Group Vice-President, Corporate Officer and CEO & President of Baxter's Global Renal Business. Mr. Joseph successfully led the strategic development, implementation and growth of Baxter, increasing revenuew from $20 million to $2 billion.
« Plan4Demand Opens New Office | | DFJ Element Closes $284 Million Venture Fund »
